Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 333 followers

Latest posts

Last updated about 7 hours ago

Human medicines European public assessment report (EPAR): Loqtorzi, toripalimab, Date of authorisation: 19/09/2024, Revision: 5, Status: Authorised

about 7 hours ago

Human medicines European public assessment report (EPAR): Loqtorzi, toripalimab, Date of authorisation...

Human medicines European public assessment report (EPAR): Silapo, epoetin zeta, Date of authorisation: 18/12/2007, Revision: 18, Status: Authorised

about 7 hours ago

Human medicines European public assessment report (EPAR): Silapo, epoetin zeta, Date of...

Human medicines European public assessment report (EPAR): Elmiron, pentosan polysulfate sodium, Date of authorisation: 02/06/2017, Revision: 15, Status: Authorised

about 7 hours ago

Human medicines European public assessment report (EPAR): Elmiron, pentosan polysulfate sodium, Date...

Human medicines European public assessment report (EPAR): Obodence, denosumab, Date of authorisation: 12/02/2025, Revision: 5, Status: Authorised

about 7 hours ago

Human medicines European public assessment report (EPAR): Obodence, denosumab, Date of authorisation...

Enpr-EMA priority activities

about 13 hours ago

Enpr-EMA priority activities

Human medicines European public assessment report (EPAR): Dzuveo, sufentanil, Date of authorisation: 25/06/2018, Revision: 9, Status: Authorised

about 8 hours ago

Human medicines European public assessment report (EPAR): Dzuveo, sufentanil, Date of authorisation...

Human medicines European public assessment report (EPAR): Vyxeos liposomal (previously Vyxeos), daunorubicin,cytarabine, Date of authorisation: 23/08/2018, Revision: 11, Status: Authorised

about 8 hours ago

Human medicines European public assessment report (EPAR): Vyxeos liposomal (previously Vyxeos), daunorubicin,cytarabine...

Silapo : EPAR - All Authorised presentations

about 22 hours ago

Silapo : EPAR - All Authorised presentations

Orphan designation: tobevibart Treatment of hepatitis delta virus infection, 13/12/2024 Positive

about 8 hours ago

Orphan designation: tobevibart Treatment of hepatitis delta virus infection, 13/12/2024 Positive

Orphan designation: Measles virus Schwarz strain (live, attenuated) Treatment of mesothelioma, 23/02/2026 Positive

about 8 hours ago

Orphan designation: Measles virus Schwarz strain (live, attenuated) Treatment of mesothelioma, 23/02/2026...

Orphan designation: recombinant human surfactant protein D Prevention of bronchopulmonary dysplasia, 11/04/2014 Positive

about 13 hours ago

Orphan designation: recombinant human surfactant protein D Prevention of bronchopulmonary dysplasia, 11/04/2014...

Orphan designation: mRNA encoding Cas12HF endonuclease, Single guide RNA against the human HAO1 gene Treatment of primary hyperoxaluria, 22/08/2025 Positive

about 8 hours ago

Orphan designation: mRNA encoding Cas12HF endonuclease, Single guide RNA against the human...